Literature DB >> 25195870

Proteomics in neurodegenerative diseases: Methods for obtaining a closer look at the neuronal proteome.

Sarah Plum1, Simone Steinbach2, Laura Abel2, Katrin Marcus1, Stefan Helling1, Caroline May2.   

Abstract

The analysis of brain function in normal aging and neurodegenerative, psychiatric, and neurological diseases has long been a subject of interest and has historically been investigated through descriptive analysis of macroscopic or microscopic observations. It is now possible to characterize brain cells, such as neurons and glial cells, or even their subcellular components, at the molecular level. This ability enables researchers to more closely examine brain cell specific molecular pathways to elucidate distinct brain functions. Furthermore, the analysis of neuronal maintenance and disease-causing effects is a central component of neurological investigations, which include proteomic approaches. Proteomics allows the identification of thousands of proteins through descriptive and comparative analyses and can provide a detailed overview of a distinct cellular state. Such analyses often require the isolation of individual cell types or subcellular components to investigate specific questions. This review provides an overview of the currently applied state-of-the-art prefractionation strategies in this field.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Laser-capture microdissection; Lewy bodies; Mitochondria; Neuromelanin granule; Synaptosomes

Mesh:

Substances:

Year:  2014        PMID: 25195870     DOI: 10.1002/prca.201400030

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  5 in total

1.  Enrichment of single neurons and defined brain regions from human brain tissue samples for subsequent proteome analysis.

Authors:  Mariana Molina; Simone Steinbach; Young Mok Park; Su Yeong Yun; Ana Tereza Di Lorenzo Alho; Helmut Heinsen; Lea T Grinberg; Katrin Marcus; Renata E Paraizo Leite; Caroline May
Journal:  J Neural Transm (Vienna)       Date:  2015-06-30       Impact factor: 3.575

2.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Authors:  Fabio A Zucca; Renzo Vanna; Francesca A Cupaioli; Chiara Bellei; Antonella De Palma; Dario Di Silvestre; Pierluigi Mauri; Sara Grassi; Alessandro Prinetti; Luigi Casella; David Sulzer; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-06-05

3.  Proteomic Analysis of Mitochondria-Enriched Fraction Isolated from the Frontal Cortex and Hippocampus of Apolipoprotein E Knockout Mice Treated with Alda-1, an Activator of Mitochondrial Aldehyde Dehydrogenase (ALDH2).

Authors:  Aneta Stachowicz; Rafał Olszanecki; Maciej Suski; Katarzyna Głombik; Agnieszka Basta-Kaim; Dariusz Adamek; Ryszard Korbut
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923

4.  Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson's Disease.

Authors:  Sarah Plum; Britta Eggers; Stefan Helling; Markus Stepath; Carsten Theiss; Renata E P Leite; Mariana Molina; Lea T Grinberg; Peter Riederer; Manfred Gerlach; Caroline May; Katrin Marcus
Journal:  Cells       Date:  2020-12-02       Impact factor: 6.600

5.  Label-free mass spectrometric analysis reveals complex changes in the brain proteome from the mdx-4cv mouse model of Duchenne muscular dystrophy.

Authors:  Sandra Murphy; Margit Zweyer; Michael Henry; Paula Meleady; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  Clin Proteomics       Date:  2015-11-23       Impact factor: 3.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.